Curcumin suppresses colorectal cancer by inhibiting TRIM2 and mTOR signaling

Hang Yu1, Haikuo Wu1, Qianhui Zhao1

  • 1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China; National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.

Translational Oncology
|September 14, 2025
PubMed

Insights

Curcumin, a natural compound, inhibits colorectal cancer (CRC) by reducing tripartite motif-containing protein 2 (TRIM2) and the mTOR pathway. This suggests TRIM2 as a potential prognostic marker for CRC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Natural Products Chemistry

Background:

  • Colorectal cancer (CRC) remains a significant health challenge globally.
  • The anti-cancer properties of curcumin, a natural polyphenol, are recognized, but its precise molecular targets in CRC require further investigation.
  • Understanding the molecular mechanisms of curcumin in CRC is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate whether curcumin suppresses colorectal cancer (CRC) by targeting tripartite motif-containing protein 2 (TRIM2) and its downstream Mammalian Target of Rapamycin (mTOR) signaling pathway.
  • To elucidate the molecular mechanisms underlying curcumin's anti-cancer effects in CRC.
  • To evaluate the potential of TRIM2 as a prognostic marker in CRC.

Main Methods:

  • Whole-genome expression profile chip analysis to identify gene alterations after curcumin administration.
  • Quantitative PCR and immunohistochemical (IHC) staining to assess TRIM2 expression in CRC cells and tissues.
  • Cell and animal experiments to evaluate the impact of TRIM2 knockdown on CRC cell proliferation and tumor growth.
  • Phospho-kinase arrays and immunoblotting to interrogate mTOR pathway activity, with pharmacologic rescue using an mTOR activator.

Main Results:

  • Curcumin significantly decreased TRIM2 expression in CRC cells.
  • Elevated TRIM2 expression was confirmed in CRC cells and tumor samples.
  • TRIM2 knockdown and curcumin administration suppressed CRC cell migration and proliferation.
  • mTOR pathway activation was dampened by TRIM2 depletion, reducing AKT and S6K/4EBP1 phosphorylation.
  • Partial reversal of curcumin's effects was observed upon mTOR pathway activation.

Conclusions:

  • Curcumin inhibits colorectal cancer (CRC) onset and progression by downregulating TRIM2 and suppressing mTOR pathway activity.
  • TRIM2 plays a critical role in CRC proliferation and migration via the mTOR signaling pathway.
  • TRIM2 may serve as a potential prognostic marker for colorectal cancer (CRC).

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.7K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K